Form 8-K - Current report:
SEC Accession No. 0001193125-21-324522
Filing Date
2021-11-09
Accepted
2021-11-09 16:26:59
Documents
17
Period of Report
2021-11-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d243582d8k.htm   iXBRL 8-K 32150
2 EX-99.1 d243582dex991.htm EX-99.1 31388
3 EX-99.2 d243582dex992.htm EX-99.2 19451
4 EX-99.3 d243582dex993.htm EX-99.3 157345
8 GRAPHIC g243582g1104095603333.jpg GRAPHIC 3240
9 GRAPHIC g243582g1104095603599.jpg GRAPHIC 2807
  Complete submission text file 0001193125-21-324522.txt   417744

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA zlab-20211108.xsd EX-101.SCH 2874
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE zlab-20211108_lab.xml EX-101.LAB 18840
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zlab-20211108_pre.xml EX-101.PRE 11827
10 EXTRACTED XBRL INSTANCE DOCUMENT d243582d8k_htm.xml XML 3561
Mailing Address 4560 JINKE ROAD BLDG. 1, 4F, PUDONG SHANGHAI F4 201210
Business Address 4560 JINKE ROAD BLDG. 1, 4F, PUDONG SHANGHAI F4 201210 862161632588
Zai Lab Ltd (Filer) CIK: 0001704292 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38205 | Film No.: 211392629
SIC: 2834 Pharmaceutical Preparations